Pharmaceutical Glass Packaging Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 29.77 Billion |
| Market Size (2029) | USD 38.52 Billion |
| CAGR (2024 - 2029) | 5.29 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Asia-Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Pharmaceutical Glass Packaging Market Analysis
The Pharmaceutical Glass Packaging Market size is estimated at USD 29.77 billion in 2024, and is expected to reach USD 38.52 billion by 2029, growing at a CAGR of 5.29% during the forecast period (2024-2029).
Glass packaging solutions are offered mainly as the primary packaging for pharmaceutical products and are among the leading packaging materials for the pharmaceutical industry. This is mainly due to being sustainable, inert, impermeable, and recyclable with no loss in quality and reusable advantages.
- The increasing demand for pharmaceutical drugs and medicines associated with technological advancements in the pharmaceutical industry is directly creating the demand for bottles, ampules, and other glass packaging solutions.
- With a rise in chronic diseases and a significant number of vaccine doses being manufactured for COVID-19, the demand for primary packaging is anticipated to rise, especially glass containers.
- Moreover, the significant characteristic benefits of glass, such as chemically durable and suitability to sustain various chemical compositions, are some factors driving packaging vendors to choose glass as pharmaceutical material. Additionally, glass vials and ampoules offer improved transparency, making viewing and monitoring the contents.
- Traditionally, the preferred materials across pharmaceutical packaging have been aluminum and glass. Over time, these materials became expensive due to raw material prices and other factors and could not provide economically viable solutions for packaging products across mass consumption. That marked the advent of plastics as an option.
- The COVID-19 pandemic left a steady growth rate with increased demand for medicines. The surge in demand for pharmaceutical drugs during the pandemic has driven the market's growth. It is expected to grow as new drugs and vaccines are being approved and phased out in different countries by pharmaceutical manufacturers, expanding the scope of glass packaging.
Pharmaceutical Glass Packaging Market Trends
Growth of Pharmaceutical Industry in Emerging Economies to Drive the Market
- Emerging markets are described as growing prosperous nations where investment is anticipated to increase profits despite significant risks. The BRICS (Brazil, Russia, India, China, and South Africa) nations are the top developing economies. There are a few different approaches to classifying lower-tier economies. One only uses a select few as the MIST (Mexico, Indonesia, South Korea, and Turkey). Another interpretation separates the two groups into CIVETS (Colombia, Indonesia, Vietnam, Egypt, Turkey, and South Africa) and Bangladesh, Egypt, Indonesia, Iran, Korea, Mexico, Nigeria, Pakistan, the Philippines, Turkey, and Vietnam.
- While pharmaceutical sales grow slowly in many developed nations, emerging market sales patterns indicate ongoing expansion. Several economic and demographic variables influence the trend in these markets, such as challenging conditions in established markets, with which growth has been flattened due to patent expiration, cost-cutting measures that encourage generic replacement, and strict enforcement of restrictions.
- The pharmaceutical glass packaging industry has seen significant penetration in nations like China. Glass packaging for pharmaceuticals is becoming more widely used in developed countries. As a result of COVID-19, the healthcare and pharmaceutical sectors are growing in emerging nations, which presents the potential for the Chinese market for pharmaceutical glass packaging.
- For instance, in September 2022, SCHOTT Pharma expanded cartridge output in China. Several million investments are intended to significantly improve the manufacturing capabilities for pharmaceutical cartridges in China and Hungary.
- Additionally, R&D was highly valued in the pharmaceutical sector in India. India became a worldwide medical giant in 2022 by enlarging its R&D ecosystem and raising pharmaceutical exports, creating opportunities for various domestic glass packaging vendors.
- Overall, all these investments by significant market incumbents due to the growth of the pharmaceutical market are expected to drive market growth in the forecast period.
Asia Pacific to Witness Significant Growth
- China's pharmaceutical glass packaging market is expected to grow very fast as China has built a standard system for the pharmaceutical industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period and safety when used. Against this background, new types of green, degradable, and easy-to-use pharmaceutical packaging materials and vessels are in the palmy days.
- China's large and rapidly growing healthcare market has been an obvious target of opportunity for the glass packaging sector in China due to the presence of major multinational pharmaceutical companies, and these companies are among the most significant revenue earners in the Chinese pharmaceutical market.
- In India, pharmaceutical glass packaging has been growing due to the increasing usage of generic injectable drugs in the healthcare industry. Pharmaceutical glass packaging is available in various drug types, such as injectable and non-injectable. The significant property of pharmaceutical glass packaging has high chemical durable properties, which maximizes the reliability of the products.
- The demand for glass packaging in India is expected to grow rapidly as India is a prominent and expanding player in the global medicines market. According to data published on the India Brand Equity Foundation website, India is the world's largest provider of generic pharmaceuticals, accounting for 20% of the worldwide supply and meeting over 60% of global vaccine demand. The Indian pharmaceutical industry is valued at USD 42 billion globally.
- In Japan, the market's growth is supported by the increase in glass container shipments in end-use markets. Glass containers are one of the most preferred materials for packaging liquid-based pharmaceutical products, chemicals, and a variety of other perishable/non-perishable products. Moreover, the rising preference for environment-friendly packaging solutions impacts pharmaceutical glass packaging adoption.
- The scope of the Rest of the Asia-Pacific region includes multiple countries such as Indonesia, Australia, Singapore, Thailand, South Korea, and Malaysia. The market is driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations, and a robust generics market.
Pharmaceutical Glass Packaging Industry Overview
The pharmaceutical glass packaging market is inclined towards fragmentation. The surge in government initiatives and increasing demand for injectables and other medicines provide lucrative pharmaceutical glass packaging solutions opportunities. Overall, the competitive rivalry among existing competitors is high. Further, expansion and mergers of large companies in different pharmaceutical industries are expected to increase the demand in the market. Key players are Gerresheimer Glass Inc., Corning Incorporated, etc.
In September 2022, Gerresheimer AG and StevanatoGroup SpA developed together a high-end ready-to-use (RTU) solution platform with an initial focus on vials built on StevanatoGroup's market-leading EZ-fill technology. The customers are expected to benefit from the partnership in terms of increased productivity, higher quality standards, quicker time to market, the lower total cost of ownership (TCO), and reduced supply chain risk.
In July 2022, Nipro Corporation Japan, a Medical equipment manufacturing company, invested HRK 100 million (USD 13.6 million/EUR 13.3 million) in a new glass packaging plant for the pharmaceutical industry in Croatia. The new factory that produces glass ampoules and vials to package life-saving drugs was inaugurated in Zagreb's suburb Sesvete, Nipro's division Nipro PharmaPackaging.
Pharmaceutical Glass Packaging Market Leaders
Gerresheimer AG
Corning Incorporated
Nipro Corporation
SGD SA (SGD Pharma)
Stölzle-Oberglas GmBH (CAG Holding GmbH)
*Disclaimer: Major Players sorted in no particular order
Pharmaceutical Glass Packaging Market News
- January 2023: Aurangabad, a city in Maharashtra, India, signed an MoU worth Rs 1,650 crore (~USD 201 million) with Japan's Nipro Corporation for a glass tubing project near Pune expected to contribute to the pharma sector.
- August 2022: Gerresheimer AG announced an investment of up to USD 94 million to significantly increase its supply, logistics, and production capacity for glass vials in the United States. With contracting support from the Department of Defense, the project will be funded by the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS).
Pharmaceutical Glass Packaging Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Value Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitutes
4.3.5 Intensity of Competitive Rivalry
4.4 Assessment of Impact of COVID-19 on the Industry
5. MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Growth of Pharmaceutical Industry in Emerging Economies
5.1.2 Commodity Value of Glass Increased with Recyclability
5.2 Market Restraints
5.2.1 Increased Relevance of Alternate Material
6. MARKET SEGMENTATION
6.1 Product
6.1.1 Bottles
6.1.2 Vials
6.1.3 Ampoules
6.1.4 Cartridges and Syringes
6.1.5 Others Products
6.2 Geography
6.2.1 North America
6.2.1.1 United States
6.2.1.2 Canada
6.2.2 Europe
6.2.2.1 Germany
6.2.2.2 United Kingdom
6.2.2.3 France
6.2.2.4 Italy
6.2.2.5 Rest of Europe
6.2.3 Asia Pacific
6.2.3.1 China
6.2.3.2 India
6.2.3.3 Japan
6.2.3.4 Rest of Asia Pacific
6.2.4 Latin America
6.2.4.1 Brazil
6.2.4.2 Argentina
6.2.4.3 Rest of Latin America
6.2.5 Middle East and Africa
6.2.5.1 Saudi Arabia
6.2.5.2 South Africa
6.2.5.3 Rest of Middle East and Africa
7. COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Gerresheimer AG
7.1.2 Corning Incorporated
7.1.3 Nipro Corporation
7.1.4 SGD SA (SGD PHARMA)
7.1.5 Stlzle-Oberglas GmBH (CAG Holding GmbH)
7.1.6 Bormioli Pharma SpA
7.1.7 West Pharmaceutical Services Inc
7.1.8 Schott AG
7.1.9 Shandong Medicinal Glass Co. Ltd
7.1.10 Beatson Clark
7.1.11 Arab Pharmaceutical Glass Co.
7.1.12 Piramal Glass Private Limited (Piramal Group)
7.1.13 Sisecam Group
- *List Not Exhaustive
8. INVESTMENT ANALYSIS
9. MARKET OPPORTUNITIES AND FUTURE TRENDS
Pharmaceutical Glass Packaging Industry Segmentation
Glass packaging solutions are offered mainly as the primary packaging for pharmaceutical products and are one of the leading packaging materials, among others, for the pharmaceutical industry. The study considers revenues accrued from the sales of different glass packaging products worldwide by various vendors operating in the market. The market scope considers product types, including bottles, vials, ampoules, cartridges, syringes, and others.
The pharmaceutical glass packaging market is segmented by product (bottles, vials, ampoules, cartridges & syringes) and geography (North America (United States, Canada), Europe (Germany, United Kingdom, France, Italy), Asia Pacific (China, India, Japan), Latin America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, South Africa)). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.
| Product | |
| Bottles | |
| Vials | |
| Ampoules | |
| Cartridges and Syringes | |
| Others Products |
| Geography | |||||||
| |||||||
| |||||||
| |||||||
| |||||||
|
Pharmaceutical Glass Packaging Market Research FAQs
How big is the Pharmaceutical Glass Packaging Market?
The Pharmaceutical Glass Packaging Market size is expected to reach USD 29.77 billion in 2024 and grow at a CAGR of 5.29% to reach USD 38.52 billion by 2029.
What is the current Pharmaceutical Glass Packaging Market size?
In 2024, the Pharmaceutical Glass Packaging Market size is expected to reach USD 29.77 billion.
Who are the key players in Pharmaceutical Glass Packaging Market?
Gerresheimer AG, Corning Incorporated, Nipro Corporation, SGD SA (SGD Pharma) and Stölzle-Oberglas GmBH (CAG Holding GmbH) are the major companies operating in the Pharmaceutical Glass Packaging Market.
Which is the fastest growing region in Pharmaceutical Glass Packaging Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Pharmaceutical Glass Packaging Market?
In 2024, the Asia-Pacific accounts for the largest market share in Pharmaceutical Glass Packaging Market.
What years does this Pharmaceutical Glass Packaging Market cover, and what was the market size in 2023?
In 2023, the Pharmaceutical Glass Packaging Market size was estimated at USD 28.20 billion. The report covers the Pharmaceutical Glass Packaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pharmaceutical Glass Packaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Pharmaceutical Glass Packaging Industry Report
Statistics for the 2023 Pharmaceutical Glass Packaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pharmaceutical Glass Packaging analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
